“The dark clouds of potential US stock delisting looming large” for several major Chinese biotech companies, Scrip recently reported. The April 26 piece, titled “BeiGene, Zai Lab Look To Clear US Delisting Uncertainties,” reviews actions being ...
The 2022 edition of Chambers Global acknowledged Ropes & Gray as a leading international law firm in 48 categories across the Asia-Pacific, Europe, Latin America, and the United States, and recognized the firm’s lawyers with ...
Ropes & Gray and McKinsey & Co. co-hosted a virtual roundtable meeting for regulatory affairs leaders in the medtech industry on April 22. The event included nearly 60 attendees from leading multinational medtech companies and Chinese medtech companies ...
Visit our China site for details about Ropes & Gray’s China presence, including contact information, background on our China-based attorneys and an overview of what we offer local and international clients in the region.
